TC
ABT icon

Trilogy Capital’s Abbott ABT Stock Holding History

Trilogy Capital’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Sell
4,754
-502
-10% -$45.8K 0.02% 286
2026
Q1 		$540K Buy
5,256
+422
+9% +$47.6K 0.02% 255
2025
Q4 		$606K Buy
4,834
+87
+2% +$11.1K 0.03% 227
2025
Q3 		$636K Sell
4,747
-102
-2% -$13.4K 0.03% 226
2025
Q2 		$660K Buy
4,849
+2,361
+95% +$311K 0.03% 206
2025
Q1 		$330K Sell
2,488
-116
-4% -$14.8K 0.02% 267
2024
Q4 		$295K Buy
2,604
+101
+4% +$11.7K 0.02% 281
2024
Q3 		$285K Buy
2,503
+132
+6% +$14.5K 0.01% 282
2024
Q2 		$246K Buy
+2,371
New +$251K 0.01% 291
2022
Q1 		– Sell
-2,091
Closed -$294K – 167
2021
Q4 		$294K Buy
2,091
+51
+3% +$6.53K 0.02% 145
2021
Q3 		$241K Hold
2,040
– – 0.02% 144
2021
Q2 		$242K Buy
+2,040
New +$238K 0.02% 144
2018
Q4 		– Sell
-434
Closed -$32K – 135
2018
Q3 		$32K Buy
434
+2
+0.5% +$131 ﹤0.01% 229
2018
Q2 		$26K Buy
432
+116
+37% +$7.03K ﹤0.01% 233
2018
Q1 		$19K Buy
+316
New +$19K ﹤0.01% 223

Other funds holding ABT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Trilogy Capital's ABT Position: Q2 2026 in Review

Trilogy Capital reduced its Abbott (ABT) stake by 9.6% in Q2 2026, selling an estimated $45.8K and leaving 4,754 shares worth $431K. The position accounts for 0.02% of the portfolio, ranked #286.

Trilogy Capital first reported a position in ABT in Q1 2018 and has held it in 15 quarters since. The position peaked at $660K in Q2 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Trilogy Capital held 4,754 shares of Abbott worth $431K as of Q2 2026.
  • Trilogy Capital sold 502 Abbott shares in Q2 2026, an estimated $45.8K.
  • Abbott made up 0.02% of Trilogy Capital's portfolio in Q2 2026, its #286 holding.
  • Trilogy Capital first reported a position in Abbott in Q1 2018 and has held it in 15 quarters since.
  • Trilogy Capital's Abbott position peaked at $660K in Q2 2025.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.